Skrzypiec-Spring, M.; Sapa-Wojciechowska, A.; Rak-Pasikowska, A.; Kaczorowski, M.; Bil-Lula, I.; Hałoń, A.; Szeląg, A.
The Protective Effect of Simvastatin on the Systolic Function of the Heart in the Model of Acute Ischemia and Reperfusion Is Due to Inhibition of the RhoA Pathway and Independent of Reduction of MMP-2 Activity. Biomolecules 2022, 12, 1291.
https://doi.org/10.3390/biom12091291
AMA Style
Skrzypiec-Spring M, Sapa-Wojciechowska A, Rak-Pasikowska A, Kaczorowski M, Bil-Lula I, Hałoń A, Szeląg A.
The Protective Effect of Simvastatin on the Systolic Function of the Heart in the Model of Acute Ischemia and Reperfusion Is Due to Inhibition of the RhoA Pathway and Independent of Reduction of MMP-2 Activity. Biomolecules. 2022; 12(9):1291.
https://doi.org/10.3390/biom12091291
Chicago/Turabian Style
Skrzypiec-Spring, Monika, Agnieszka Sapa-Wojciechowska, Alina Rak-Pasikowska, Maciej Kaczorowski, Iwona Bil-Lula, Agnieszka Hałoń, and Adam Szeląg.
2022. "The Protective Effect of Simvastatin on the Systolic Function of the Heart in the Model of Acute Ischemia and Reperfusion Is Due to Inhibition of the RhoA Pathway and Independent of Reduction of MMP-2 Activity" Biomolecules 12, no. 9: 1291.
https://doi.org/10.3390/biom12091291
APA Style
Skrzypiec-Spring, M., Sapa-Wojciechowska, A., Rak-Pasikowska, A., Kaczorowski, M., Bil-Lula, I., Hałoń, A., & Szeląg, A.
(2022). The Protective Effect of Simvastatin on the Systolic Function of the Heart in the Model of Acute Ischemia and Reperfusion Is Due to Inhibition of the RhoA Pathway and Independent of Reduction of MMP-2 Activity. Biomolecules, 12(9), 1291.
https://doi.org/10.3390/biom12091291
